Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs
Supriya Lifescience Ltd
-(SUPRIYA)
XNSE:SUPRIYA, XBOM:SUPRIYA
Supriya Lifescience Ltd Q1FY24; 16% rise in Profits
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs
Supriya Lifescience Ltd (SUPRIYA) Q4 FY23 Earnings Concall Transcript
Supriya Lifescience Ltd (NSE:SUPRIYA) Q4 FY23 Earnings Concall dated May. 29, 2023. Corporate Participants: Irfan Raeen -- Investor Relations Satish Wagh --
Supriya Lifescience Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q3 FY23 Earnings Concall Management Update: [00:04:00] SUPRIYA said its primary focus remains on expanding
Supriya Lifescience Ltd (SUPRIYA) Q3 FY23 Earnings Concall Transcript
Supriya Lifescience Ltd (NSE:SUPRIYA) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Satish Wagh -- Chairman and Managing Director Saloni Wagh -- Director Krishna
Supriya Lifescience Ltd (SUPRIYA) Q2 FY23 Earnings Concall Transcript
Supriya Lifescience Ltd (NSE:SUPRIYA) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Rasika Sawant -- Investor Relation Partner Satish Wagh
Supriya Lifescience Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/LNBcyeiXX0U Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q1 FY23 Earnings Concall Management Update: SUPRIYA said the company is extending its backward
Supriya Lifescience Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/VIL70Aj2g04 Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q4 FY22 Earnings Concall Management Update: SUPRIYA said that going forward the company’s focus